Muñoz-Cuevas JH

Idioma: Español
Referencias bibliográficas: 29
Paginas: 141-147
Archivo PDF: 81.41 Kb.

FRAGMENTO

“….El creciente interés de las técnicas anestésicas intravenosas ha resultado de la disponibilidad de mejores fármacos intravenosos asociado a la toxicidad de los tradicionales agentes inhalados, así como la preocupación de la contaminación de gas en quirófano…” Paul White. 1989.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Kanto J. Pharmacocinetic implications for the clinical use of propofol. Clin Pharmacokinet 1989;17(5):308-326.

2. Kruger-Theimer E. Continous intravenous infusion and multicompartmenn accumulation. Eur J Pharmacol 1968;4:317-324.

3. Schwilden H. A general method for calculating the dosage scheme in linear pharmacokinetics. Eur J Pharmacol 1981; 20:379-380.

4. Smith C. The interaction of fentanil on the Cp 50 of propofol for loss of consciousness and skin incision. Anesthesiology 1994;81(4):820-828.

5. Schnider TW. The effect compartment in pharmacodynamic modeling. Anesthetic Pharmacology Review 1994;2:204-213.

6. Schnider TW. The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology 1998;88(5):1170-1182.

7. Schafer SL. Algorithm of rapidly achieve and maintain stable concentrations at the site of drug effect with a computer-controlled infusion pump. J Pharmacokinetic Biopharma 1992; 20:147-169.

8. Doze VA. Propofol-nitrous oxide versus thiopental-isofluoranenitrous oxide for general anesthesia. Anesthesiology 1988;69:6371-6380.

9. Lee JA. history of Anaesthesia, Lee´s synopsis of Anaesthesia, II Edition. Edited by Atkinson RS, Rushman GA, Davis NJH. Oxford, Butterworth Heinemann, 1996: 875-915.

10. Sepúlveda P. ¿Cómo construir una TIVA en forma manual? La Anestesia Intravenosa Bases Teóricas y Experiencias Clínicas. Primera Edición. Editor: Universidad del Desarrollo, Santiago de Chile, Enero 2004: 61-69.

11. White P. Clinical uses of intravenous anesthetic an analgesic infusions. Anesth Analg 1989;68:161-171.

12. Vuyk J. Propofol anesthesia and rational opioid selection: determination of optimal EC50-EC95 propofol concentrations that assure adequate anaesthesia and a rapid return of consciousness. Anesthesiology 1997;87:1549-1562.

13. Kezama T. Pharmacodymanic interaction between propofol and fentanilo with respect to the suppression of somatic or hemodynamic response to skin incision, peritoneum incision and abdominal wall retraction. Anesthesiology 1998;89:894-906.

14. Gepts E. Linearity of pharmacokinetics and model estimation of sufentanil. Anesthesiology 1995;83(6):1196-1204.

15. Maitre PO. Population pharmacokinetics of alfentanil: the average dose-plasma concentrations relationship and interindividual variability in patients. Anesthesiology 1987;66(1):3-12.

16. Minto CF. Pharmacokinetics and pharmocodynamic of remifentanil (II); model application. Anesthesiology 1997;86(1):24-33.

17. Bovil JG. Adverse drugs interactions in anesthesia. J Clin Anesth 1997;9(6 Suppl):3-13S.

18. Mertens MJ. Performance of computer-controlled infusion of remifentanil during propofol-remifentanil anesthesia. Br J Anaesth 2003;90(2):132-141.

19. Egan TD. Remifentanil versus alfentanil: comparative pharmacokinetics and pharmacodynamic in healthy adult male volunteers. Anesthesiology 1996;84(4):821-833.

20. Vuyk J. Performance of computer-controlled infusion of propofol: an evaluation of five pharmacodynamic parameter sets. Anesth Analg 1995;81(6):1275-1282.

21. Moerman N. Awareness and recall during general anesthesia. Anesthesiology 1993;79:454-464.

22. Carrasco MS. Monitoring of autonomic nervous system response to gynecological procedures under TIVA. 10th. ISAP Annual Meeting Refresher Lectures. October 2001. 14.

23. Rampill I. A primer for EEG signal processing in anesthesia. Anesthesiology 1998;89:980-1002.

24. Glass PS Biespectral Analysis measures sedation and memory effects of propofol, midazolam, isofluorano and alfentanil in healthy volunteers. Anesthesiology 1997;86(4):836-847.

25. Struys MM. Comparison of plasma compartment versus two methods for effect compartment-controlled target-controlled infusion for propofol. Anesthesiology 2000;92:399-406.

26. Drover D. Patient State Index. Anesthesiology 2002;97(1):82-88.

27. Struys MM. Comparison of closed-loop controlled administration using Biespectral index as the controlled variable versus “standard practice” controlled administration. Anesthesiology 2001;95(1):6-17.

28. Bell SL. The auditory middle latency response. Evoked using maximum length sequences and chirps, as an indicator of adequacy of anesthesia. Anesth Analg 2006;102:495-498.

29. Lichtenbelt BJ. Strategies to optimise propofol-opioid anaesthesia. Clin Pharmacokinet 2004;43(9):577-593.